by Haja Mo May 27, 2026 Business The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens. Previous Story BP Ousts Chairman, Citing ‘Serious Concerns’ Over Conduct Next Story G.D.P. Is a Flawed Measure of Prosperity. Alternatives Are On the Way.
